Phagocytosis News and Research

RSS
Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

Precision cut slice lung model to study early host viral pathogenesis of SARS-CoV-2 infection

Precision cut slice lung model to study early host viral pathogenesis of SARS-CoV-2 infection

Discovery of novel antibody that targets shared epitope on SARS-CoV-2 variants

Discovery of novel antibody that targets shared epitope on SARS-CoV-2 variants

SARS-CoV-2 infection patterns in olfactory epithelium

SARS-CoV-2 infection patterns in olfactory epithelium

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

SARS-CoV-2 ORF8 interferes with antibody-dependent cellular cytotoxicity

SARS-CoV-2 ORF8 interferes with antibody-dependent cellular cytotoxicity

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Study reveals how the immune system can be triggered to attack cancer cells

Study reveals how the immune system can be triggered to attack cancer cells

Study reveals how the immune system can be triggered to fight cancer cells

Study reveals how the immune system can be triggered to fight cancer cells

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Melatonin as a safe and potentially life-saving treatment for COVID-19

Melatonin as a safe and potentially life-saving treatment for COVID-19

Superior immune response in vaccinated after infection with Omicron compared to unvaccinated

Superior immune response in vaccinated after infection with Omicron compared to unvaccinated

Circadian cycle controls the brain's ability to clear a protein linked to Alzheimer's disease

Circadian cycle controls the brain's ability to clear a protein linked to Alzheimer's disease

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

Dexamethasone shown to upregulate innate and adaptive immune responses in COVID-19 acute respiratory distress syndrome patients

Dexamethasone shown to upregulate innate and adaptive immune responses in COVID-19 acute respiratory distress syndrome patients

SARS-CoV-2 appears to persist in organs throughout the body for months

SARS-CoV-2 appears to persist in organs throughout the body for months

Oral bacteria-based SARS-CoV-2 vaccine platform

Oral bacteria-based SARS-CoV-2 vaccine platform